No differences were found between WT and Nrp1-KO microglia at basal states; however, WT microglia showed an increase in SMAD2/3 activation compared to no changes in Nrp1-KO microglia when treated with GL261 glioma-conditioned medium. Here, SMAD2 is linked to central nervous system cancer.